TGF-β3 promotes vascular normalization of prostate cancer to potentiate immunotherapy and chemotherapy.
Teng Q, Wang N, Lei H, Tong T, Guan Y, Huang M, Cao F, Xu B, Yang J, Huo Y, Chen W, Bi R, Wang X, Wang Z, Tian FY, Zhao B, Pang J.
Teng Q, et al. Among authors: wang n.
Cancer Immunol Immunother. 2025 Jul 12;74(8):268. doi: 10.1007/s00262-025-04103-2.
Cancer Immunol Immunother. 2025.
PMID: 40650767